mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
0.2 |
0.5 |
mRNA |
PF-750 |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.5 |
mRNA |
spautin-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.5 |
mRNA |
austocystin d |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |